bf/NASDAQ:ALNY_icon.jpeg

COM:ALNYLAM

Alnylam Pharmaceuticals

  • Stock

USD

Last Close

246.80

22/11 21:00

Market Cap

32.60B

Beta: -

Volume Today

450.15K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
12.03M
-
40.21M
234.12%
74.33M
84.85%
107.50M
44.64%
125.83M
17.05%
109.05M
13.33%
average payables
5.16M
-
10.50M
103.64%
15.95M
51.84%
35.63M
123.37%
41.41M
16.24%
44.03M
6.33%
54.80M
24.45%
50.92M
7.06%
62.70M
23.11%
85.76M
36.79%
76.81M
10.44%
average receivables
2.18M
-
22.09M
915.28%
24.12M
9.17%
15.82M
34.42%
28.67M
81.26%
26.38M
7.98%
30.89M
17.07%
72.71M
135.42%
150.49M
106.97%
218.27M
45.04%
282.88M
29.60%
book value per share
4.39
-
12.60
186.98%
15.06
19.46%
10.75
28.60%
19.51
81.45%
12.94
33.65%
13.17
1.73%
8.84
32.88%
4.97
43.81%
-1.30
126.18%
-1.77
35.86%
capex per share
-0.07
-
-0.12
85.36%
-0.15
27.80%
-0.75
389.17%
-1.15
52.58%
-1.26
9.61%
-1.28
1.69%
-0.61
52.30%
-0.64
5.37%
-0.59
8.16%
-0.50
15.89%
capex to depreciation
-0.39
-
-0.75
91.86%
-0.68
9.53%
-4.27
527.67%
-7.80
82.71%
-19.72
152.93%
-2.58
86.93%
-0.95
63.33%
-0.85
9.92%
-0.84
1.08%
-1.15
36.64%
capex to operating cash flow
0.06
-
0.05
7.28%
0.07
26.56%
0.21
206.43%
0.27
29.76%
0.23
17.16%
0.50
123.20%
0.11
77.27%
0.12
4.02%
0.13
11.86%
-0.60
548.65%
capex to revenue
-0.08
-
-0.18
108.67%
-0.32
77.79%
-1.37
334.43%
-1.16
15.33%
-1.69
46.15%
-0.64
62.35%
-0.14
77.62%
-0.09
36.64%
-0.07
23.21%
-0.03
51.01%
cash per share
3.99
-
13.15
229.11%
15.86
20.66%
7.32
53.84%
18.67
154.95%
10.78
42.27%
14.06
30.44%
16.30
15.95%
20.56
26.14%
18.02
12.38%
19.53
8.40%
days of inventory on hand
4.88K
-
820.65
83.17%
431.64
47.40%
319.57
25.96%
278.83
12.75%
104.82
62.41%
days payables outstanding
12.09K
-
726.50
93.99%
243.01
66.55%
191.24
21.31%
212.09
10.90%
65.28
69.22%
days sales outstanding
32.87
-
288.31
777.03%
73.70
74.44%
180.60
145.05%
138.03
23.57%
91.41
33.78%
71.44
21.85%
75.85
6.17%
85.85
13.18%
83.72
2.47%
65.44
21.84%
debt to assets
0.01
-
-0.02
454.98%
0.00
119.66%
0.13
2,533.95%
0.02
83.94%
0.06
187.15%
0.24
310.53%
0.15
36.82%
0.27
79.00%
0.37
35.96%
0.64
71.10%
debt to equity
0.01
-
-0.03
363.14%
0.01
118.70%
0.18
3,197.03%
0.02
86.78%
0.07
207.57%
0.40
465.04%
0.51
27.22%
1.70
230.70%
-8.34
591.99%
-11.06
32.50%
dividend yield
earnings yield
-0.02
-
-0.05
121.87%
-0.04
26.66%
-0.13
248.83%
-0.04
66.66%
-0.10
143.35%
-0.07
32.18%
-0.06
18.44%
-0.04
26.07%
-0.04
7.87%
-0.02
52.92%
enterprise value
3.90B
-
6.32B
61.94%
6.63B
4.79%
3.16B
52.29%
10.89B
244.49%
6.94B
36.23%
12.34B
77.72%
14.97B
21.30%
20.26B
35.37%
29.37B
44.95%
25.78B
12.24%
enterprise value over ebitda
-42.01
-
172.99
511.77%
-22.38
112.94%
-7.45
66.74%
-21.78
192.48%
-8.31
61.82%
-13.14
58.01%
-19.41
47.78%
-28.58
47.21%
-32.84
14.92%
-113.00
244.10%
ev to operating cash flow
-56.87
-
-38.17
32.88%
-35.03
8.23%
-10.27
70.68%
-28.45
176.91%
-12.34
56.62%
-44.32
259.12%
-24.34
45.08%
-31.58
29.73%
-54.27
71.84%
247.50
556.07%
ev to sales
82.78
-
125.06
51.07%
161.23
28.92%
67.03
58.43%
121.11
80.68%
92.70
23.46%
56.16
39.42%
30.37
45.91%
24.00
20.98%
28.31
17.96%
14.10
50.20%
free cash flow per share
-1.18
-
-2.35
99.12%
-2.41
2.36%
-4.35
80.75%
-5.38
23.66%
-6.85
27.46%
-3.83
44.11%
-5.96
55.58%
-6.06
1.71%
-5.04
16.86%
0.34
106.66%
free cash flow yield
-0.02
-
-0.02
31.99%
-0.03
5.47%
-0.12
354.49%
-0.04
63.56%
-0.09
122.10%
-0.03
64.62%
-0.05
37.86%
-0.04
22.05%
-0.02
40.67%
0.00
108.27%
graham net net
1.61
-
11.62
623.40%
14.49
24.67%
3.52
75.67%
16.43
366.13%
8.33
49.33%
5.86
29.63%
-3.42
158.40%
-3.46
0.97%
-10.43
201.88%
-10.57
1.38%
graham number
11.97
-
37.10
209.93%
34.21
7.79%
34.04
0.48%
48.78
43.28%
46.95
3.74%
49.02
4.39%
38.53
21.40%
28.36
26.38%
16.49
41.86%
11.84
28.23%
income quality
0.77
-
0.46
40.27%
0.65
41.87%
0.75
15.07%
0.78
3.93%
0.74
5.25%
0.31
57.47%
0.72
128.03%
0.75
5.01%
0.48
36.40%
-0.24
149.44%
intangibles to total assets
0
-
-0.52
Infinity%
0
100%
0
0
0
0
0
0
0.07
Infinity%
0.18
144.22%
interest coverage
-86.94
-
-158.26
82.02%
-50.52
68.08%
-51.11
1.16%
-40.87
20.03%
-27.84
31.88%
-9.80
-
-4.95
49.46%
-5.03
1.59%
-2.33
53.75%
interest debt per share
0.06
-
-0.32
599.95%
0.15
146.21%
1.98
1,223.36%
0.59
70.38%
1.21
106.66%
5.31
337.11%
5.27
0.76%
9.63
82.81%
12.13
25.98%
20.50
69.00%
inventory turnover
0.07
-
0.44
494.05%
0.85
90.12%
1.14
35.07%
1.31
14.61%
3.48
166.00%
invested capital
0.01
-
-0.03
363.14%
0.01
118.70%
0.18
3,197.03%
0.02
86.78%
0.07
207.57%
0.40
465.04%
0.51
27.22%
1.70
230.70%
-8.34
591.99%
-11.06
32.50%
market cap
3.96B
-
7.20B
82.05%
7.91B
9.74%
3.20B
59.47%
11.50B
259.00%
7.33B
36.25%
12.58B
71.58%
14.94B
18.76%
20.09B
34.41%
28.92B
43.97%
23.91B
17.33%
net current asset value
208.45M
-
882.86M
323.54%
1.24B
40.10%
646.65M
47.72%
1.55B
140.40%
936.48M
39.76%
777.49M
16.98%
-230.99M
129.71%
-186.32M
19.34%
-1.01B
443.33%
-1.07B
5.48%
net debt to ebitda
0.57
-
-24.13
4,317.70%
4.33
117.94%
0.10
97.63%
1.23
1,097.83%
0.47
62.04%
0.26
44.54%
-0.03
112.32%
-0.25
684.84%
-0.51
102.58%
-8.20
1,515.46%
net income per share
-1.45
-
-4.85
234.71%
-3.45
28.82%
-4.79
38.73%
-5.42
13.14%
-7.57
39.65%
-8.11
7.13%
-7.46
7.96%
-7.20
3.54%
-9.30
29.11%
-3.52
62.08%
operating cash flow per share
-1.12
-
-2.23
99.92%
-2.25
0.98%
-3.59
59.64%
-4.23
17.59%
-5.59
32.31%
-2.55
54.44%
-5.35
109.88%
-5.42
1.29%
-4.45
17.89%
0.83
118.75%
payables turnover
0.03
-
0.50
1,564.69%
1.50
198.96%
1.91
27.07%
1.72
9.83%
5.59
224.87%
receivables turnover
11.10
-
1.27
88.60%
4.95
291.20%
2.02
59.19%
2.64
30.84%
3.99
51.00%
5.11
27.95%
4.81
5.81%
4.25
11.65%
4.36
2.53%
5.58
27.94%
research and ddevelopement to revenue
2.39
-
3.76
57.12%
6.73
78.80%
8.11
20.52%
4.34
46.42%
6.75
55.30%
2.98
55.82%
1.33
55.43%
0.94
29.38%
0.85
9.28%
0.55
35.46%
return on tangible assets
-0.21
-
-0.22
3.62%
-0.21
4.84%
-0.32
55.23%
-0.25
24.23%
-0.48
96.50%
-0.37
23.49%
-0.25
31.91%
-0.23
7.08%
-0.34
47.25%
-0.14
59.22%
revenue per share
0.77
-
0.68
11.17%
0.49
28.12%
0.55
12.60%
0.99
80.22%
0.74
25.00%
2.01
170.07%
4.29
113.12%
7.13
66.29%
8.53
19.61%
14.64
71.70%
roe
-0.33
-
-0.38
16.63%
-0.23
40.42%
-0.45
94.31%
-0.28
37.65%
-0.58
110.47%
-0.62
5.31%
-0.84
37.12%
-1.45
71.67%
7.15
593.08%
2.00
72.09%
roic
-0.33
-
-0.40
21.32%
-0.21
46.87%
-0.37
73.89%
-0.26
29.13%
-0.58
122.95%
-0.40
30.75%
-0.45
9.91%
-0.37
16.46%
-0.54
44.64%
-0.12
78.36%
sales general and administrative to revenue
0.58
-
0.88
52.98%
1.47
67.47%
1.89
28.47%
2.22
17.03%
5.10
130.20%
2.18
57.30%
1.19
45.23%
0.74
38.43%
0.74
1.06%
0.44
41.42%
shareholders equity per share
4.39
-
12.60
186.98%
15.06
19.46%
10.75
28.60%
19.51
81.45%
12.94
33.65%
13.17
1.73%
8.84
32.88%
4.97
43.81%
-1.30
126.18%
-1.77
35.86%
stock based compensation to revenue
0.44
-
0.65
48.97%
1.11
70.37%
1.60
43.76%
1.03
35.54%
2.11
104.00%
0.80
62.22%
0.28
64.33%
0.20
30.84%
0.22
13.27%
0.12
45.46%
tangible asset value
270.35M
-
1.50B
453.33%
1.26B
15.46%
920.22M
27.24%
1.77B
91.96%
1.30B
26.29%
1.44B
10.50%
1.02B
29.36%
588.20M
42.12%
-422.79M
171.88%
-918.43M
117.23%
tangible book value per share
4.39
-
12.60
186.98%
15.06
19.46%
10.75
28.60%
19.51
81.45%
12.94
33.65%
13.17
1.73%
8.84
32.88%
4.97
43.81%
-3.47
169.97%
-7.35
111.64%
working capital
208.45M
-
882.86M
323.54%
1.24B
40.10%
796.65M
35.59%
1.58B
98.90%
966.48M
39.01%
777.49M
19.55%
1.03B
32.71%
1.68B
62.57%
1.92B
14.72%
2.01B
4.71%

All numbers in USD (except ratios and percentages)